The Indian pharma industry has risen to the occasion and has made efforts to ensure that medicines and vaccines reach people during the pandemic.
Read more: The pandemic has accelerated our efforts towards achieving self-reliance - ET HealthWorld
Tuesday, August 31, 2021
Pharma Reviews: Need to strengthen health infra: Sitharaman - Mint
In a bid to improve medical infrastructure in India, Sitharaman had announced the ... medical fraternity, pharma industry or medical devices players at the ...
Read more: Need to strengthen health infra: Sitharaman - Mint
Read more: Need to strengthen health infra: Sitharaman - Mint
Pharma Reviews: We are working with 700 plus pharmaceutical companies to build their future-proof business ...
How is the Indian pharma industry looking at technology modernization? The role of India's pharmaceutical industry, as the largest provider of generic drugs ...
Read more: We are working with 700 plus pharmaceutical companies to build their future-proof business ...
Read more: We are working with 700 plus pharmaceutical companies to build their future-proof business ...
Pharma Reviews: India Gdp News Highlights: Country On Track To Achieve World'S Fastest Growth This Year ...
We also see a good pickup in industrial activity across all our clients from varied sectors and remain optimistic on a continuing upswing in the economy.
Read more: India Gdp News Highlights: Country On Track To Achieve World'S Fastest Growth This Year ...
Read more: India Gdp News Highlights: Country On Track To Achieve World'S Fastest Growth This Year ...
Pharma Reviews: Sensex closes at 57,552, Nifty at 17,132 on metal surge; all eyes on GDP data - Mint
Sun Pharma and specialty pharma firm Cassiopea SpA on Tuesday announced ... Indian stock markets continued to soar to new highs today with Nifty crossing ...
Read more: Sensex closes at 57,552, Nifty at 17,132 on metal surge; all eyes on GDP data - Mint
Read more: Sensex closes at 57,552, Nifty at 17,132 on metal surge; all eyes on GDP data - Mint
US FDA News: Coronavirus (COVID-19) Update: August 31, 2021
Coronavirus (COVID-19) Update: August 31, 2021
Read more: Coronavirus (COVID-19) Update: August 31, 2021
Read more: Coronavirus (COVID-19) Update: August 31, 2021
Monday, August 30, 2021
US FDA News: Teligent Pharma, Inc.’s Issues Voluntary Recall of Lidocaine HCl Topical Solution 4% (Lot # 14218, Exp. 09/2022) Due to Super Potency
Teligent Pharma, Inc. is voluntarily recalling one lot of Lidocaine HCl Topical Solution 4%, 50ml in a screw cap glass bottle to the user level. The product is being recalled because the firms testing has found it to be super potent based on an Out of Specification (OOS) result obtained at the 18-m
Read more: Teligent Pharma, Inc.’s Issues Voluntary Recall of Lidocaine HCl Topical Solution 4% (Lot # 14218, Exp. 09/2022) Due to Super Potency
Read more: Teligent Pharma, Inc.’s Issues Voluntary Recall of Lidocaine HCl Topical Solution 4% (Lot # 14218, Exp. 09/2022) Due to Super Potency
Sunday, August 29, 2021
Pharma Reviews: There is little investment in R&D to generate robust evidence in probiotics - ET HealthWorld
The Indian probiotic market of supplements/drugs, delivered in capsules, ... we didn't get support from any stakeholders, including the pharma industry.
Read more: There is little investment in R&D to generate robust evidence in probiotics - ET HealthWorld
Read more: There is little investment in R&D to generate robust evidence in probiotics - ET HealthWorld
Pharma Reviews: The Game-Changers | Kolkata News - Times of India
With the mushrooming of several IT firms at Salt Lake's Sector V, ... to more than 100 Indian labs, both in pharma industry and academia,” Bhutoria said.
Read more: The Game-Changers | Kolkata News - Times of India
Read more: The Game-Changers | Kolkata News - Times of India
Saturday, August 28, 2021
Pharma Reviews: Huge Patent opportunity to support pharma sector - The Asian Age
Chennai: With $240 billion worth patented drugs going off-patent in the next few years, Indian pharma industry has a potential to add $15 billion to become ...
Read more: Huge Patent opportunity to support pharma sector - The Asian Age
Read more: Huge Patent opportunity to support pharma sector - The Asian Age
Pharma Reviews: Acute shortage of equipment faced by pharma companies and rise in APIs to affect drug ...
Indian vaccine manufacturers face a crucial shortage of equipment including small- and large-scale bioreactors and fermenters, a report 'Pharma Industry: ...
Read more: Acute shortage of equipment faced by pharma companies and rise in APIs to affect drug ...
Read more: Acute shortage of equipment faced by pharma companies and rise in APIs to affect drug ...
Pharma Reviews: Latest India business news headlines today 27 August 2021
India's pharma industry to reach a size of over $60 billion in the next 2 years as per CARE Ratings. PhonePe has recently announced that it processes almost 1.5 ...
Read more: Latest India business news headlines today 27 August 2021
Read more: Latest India business news headlines today 27 August 2021
Pharma Reviews: Indian Pharma industry to grow at 11 percent, surpass USD 60 billion in 2 years: Care Ratings
The domestic pharma industry globally ranks third in terms of volume and 13th in value terms, which is primarily because of the predominance of generics. The ...
Read more: Indian Pharma industry to grow at 11 percent, surpass USD 60 billion in 2 years: Care Ratings
Read more: Indian Pharma industry to grow at 11 percent, surpass USD 60 billion in 2 years: Care Ratings
Friday, August 27, 2021
US FDA News: Coronavirus (COVID-19) Update: August 27, 2021
Coronavirus (COVID-19) Update: August 27, 2021
Read more: Coronavirus (COVID-19) Update: August 27, 2021
Read more: Coronavirus (COVID-19) Update: August 27, 2021
US FDA News: FDA Approves First-of-Its-Kind Stroke Rehabilitation System
The FDA approved the MicroTransponder Vivistim Paired VNS System, a rehabilitation system intended to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulation.
Read more: FDA Approves First-of-Its-Kind Stroke Rehabilitation System
Read more: FDA Approves First-of-Its-Kind Stroke Rehabilitation System
Thursday, August 26, 2021
Pharma Reviews: Analysts See Two Key Segments Driving Growth For India-Focused Drugmakers - BloombergQuint
Sales in the Indian pharmaceutical market jumped 37.2% over the year earlier in the quarter ended June 2021, according to Prabhudas Lilladher.
Read more: Analysts See Two Key Segments Driving Growth For India-Focused Drugmakers - BloombergQuint
Read more: Analysts See Two Key Segments Driving Growth For India-Focused Drugmakers - BloombergQuint
Pharma Reviews: Pharma to hit $60bn mkt size in 2 yrs on generics - Times of India
Mumbai: The domestic pharma industry is expected to grow about 11% over the next ... for Indian pharma companies due to patent expiries of drugs globally, ...
Read more: Pharma to hit $60bn mkt size in 2 yrs on generics - Times of India
Read more: Pharma to hit $60bn mkt size in 2 yrs on generics - Times of India
Pharma Reviews: Equipment shortage, high API cost affects drug availability during Covid: Infomerics
The report also highlights the gap in diagnostic services in India, particularly in rural India. Image Credit: Shutterstock. Indian vaccine manufacturers ...
Read more: Equipment shortage, high API cost affects drug availability during Covid: Infomerics
Read more: Equipment shortage, high API cost affects drug availability during Covid: Infomerics
Pharma Reviews: Monster Employment Index: Hiring activity sees positive growth across most Indian metros ...
Overall, hiring activity in Healthcare, Bio Technology & Life Sciences, Pharmaceuticals industry witnessed a 12% decline year-on-year (July 2021 vs.
Read more: Monster Employment Index: Hiring activity sees positive growth across most Indian metros ...
Read more: Monster Employment Index: Hiring activity sees positive growth across most Indian metros ...
Pharma Reviews: Indian Pharma Industry to surpass $60 billion in two years - Mint
The Indian domestic pharma market which was at about $18 bn during FY17 has exhibited a CAGR of about 4.5% to reach $21 bn during FY21. Further, the pharma ...
Read more: Indian Pharma Industry to surpass $60 billion in two years - Mint
Read more: Indian Pharma Industry to surpass $60 billion in two years - Mint
Pharma Reviews: Acute shortage of equipments faced by Pharma Cos, rise in APIs, to affect drug availability ...
Indian vaccine manufacturers face a crucial shortage of equipment including small- and large-scale bioreactors and fermenters.The report reveals that the ...
Read more: Acute shortage of equipments faced by Pharma Cos, rise in APIs, to affect drug availability ...
Read more: Acute shortage of equipments faced by Pharma Cos, rise in APIs, to affect drug availability ...
Pharma Reviews: Target: A $120 Billion Industry - BusinessToday
Innovation and universal healthcare can make the Indian pharmaceutical industry a force to reckon with by 2030. Illustration by Nilanjan Das.
Read more: Target: A $120 Billion Industry - BusinessToday
Read more: Target: A $120 Billion Industry - BusinessToday
US FDA News: FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health
FDA issued marketing denial orders for flavored e-cigarettes after determining applications lacked sufficient evidence.
Read more: FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health
Read more: FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health
US FDA News: FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods
FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods; Nearly all foods tested had no detectable levels of PFAS; no evidence that levels found in samples indicate need to avoid particular foods
Read more: FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods
Read more: FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods
US FDA News: Mammography Problems at Madison Avenue Radiology Center 190th Broadway in New York, New York: FDA Safety Communication
The FDA is alerting patients who had mammograms at Madison Ave Radiology Center on or after February 26, 2019 about possible problems with their mammograms.
Read more: Mammography Problems at Madison Avenue Radiology Center 190th Broadway in New York, New York: FDA Safety Communication
Read more: Mammography Problems at Madison Avenue Radiology Center 190th Broadway in New York, New York: FDA Safety Communication
US FDA News: UPDATE: The FDA Reminds Patients and Health Care Providers of the Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication
The FDA is updating our October 28, 2019 safety communication on the use of AFX endovascular grafts with Duraply material (AFX with Duraply or AFX2).
Read more: UPDATE: The FDA Reminds Patients and Health Care Providers of the Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication
Read more: UPDATE: The FDA Reminds Patients and Health Care Providers of the Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication
Wednesday, August 25, 2021
Pharma Reviews: Indian pharma export target worth USD 126 million in FY22 on blink amid Afghan crisis
Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as ...
Read more: Indian pharma export target worth USD 126 million in FY22 on blink amid Afghan crisis
Read more: Indian pharma export target worth USD 126 million in FY22 on blink amid Afghan crisis
US FDA News: Stop Using Certain N95 Respirators Manufactured by Shanghai Dasheng - Letter to Health Care Providers
NIOSH revoked all respirator approvals previously issued to Shanghai Dasheng
Read more: Stop Using Certain N95 Respirators Manufactured by Shanghai Dasheng - Letter to Health Care Providers
Read more: Stop Using Certain N95 Respirators Manufactured by Shanghai Dasheng - Letter to Health Care Providers
Tuesday, August 24, 2021
Pharma Reviews: Indian pharma exporters stare at Afghan uncertainty; $126 million target in FY22 on blink
Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the ...
Read more: Indian pharma exporters stare at Afghan uncertainty; $126 million target in FY22 on blink
Read more: Indian pharma exporters stare at Afghan uncertainty; $126 million target in FY22 on blink
Pharma Reviews: India pips US to rank 2nd in list of most attractive manufacturing hub globally; China 1st ...
"This switch in ranking is attributed to the plant relocations from China to other parts of Asia due to an already established base in pharma, chemicals and ...
Read more: India pips US to rank 2nd in list of most attractive manufacturing hub globally; China 1st ...
Read more: India pips US to rank 2nd in list of most attractive manufacturing hub globally; China 1st ...
US FDA News: Coronavirus (COVID-19) Update: August 24, 2021
Coronavirus (COVID-19) Update: August 24, 2021
Read more: Coronavirus (COVID-19) Update: August 24, 2021
Read more: Coronavirus (COVID-19) Update: August 24, 2021
Monday, August 23, 2021
Pharma Reviews: Share price of Torrent Pharma jumps as Sensex gains 140.62 points - The Economic Times
Torrent Pharmaceuticals Ltd. belongs to the Pharma - Indian industry. Promotor/FII Holding Promoters held 71.25 per cent stake in the company as of 30-Jun-2021, ...
Read more: Share price of Torrent Pharma jumps as Sensex gains 140.62 points - The Economic Times
Read more: Share price of Torrent Pharma jumps as Sensex gains 140.62 points - The Economic Times
Pharma Reviews: Aurobindo Pharma shares up 3.25% as Nifty gains - The Economic Times
Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a ... Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Read more: Aurobindo Pharma shares up 3.25% as Nifty gains - The Economic Times
Read more: Aurobindo Pharma shares up 3.25% as Nifty gains - The Economic Times
Pharma Reviews: Work on non-Covid vaccines gives pharma firms an injection of hope | Business Standard News
Injecting hope into the veins of pharmaceutical (pharma) companies in India, work on non-Covid vaccines slowly gathers pace in the country.
Read more: Work on non-Covid vaccines gives pharma firms an injection of hope | Business Standard News
Read more: Work on non-Covid vaccines gives pharma firms an injection of hope | Business Standard News
Pharma Reviews: Indian investors traded global stocks for over $120 mn in March quarter: Report - Mint
Investors are diversifying away from tech stocks to pharma companies, airlines and companies that are expected to benefit from Biden's infrastructure plan.
Read more: Indian investors traded global stocks for over $120 mn in March quarter: Report - Mint
Read more: Indian investors traded global stocks for over $120 mn in March quarter: Report - Mint
Pharma Reviews: With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former ...
There is also big support from the government for API. Agencies A Vaidheesh, former managing director, GlaxoSmithKline Pharmaceuticals. In an interview with ET ...
Read more: With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former ...
Read more: With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former ...
Pharma Reviews: India emerges as second most attractive manufacturing hub globally, says report - The ...
The switch in the US and India's ranking is attributed to the plant relocations from China to other parts of Asia due to an already established base in pharma, ...
Read more: India emerges as second most attractive manufacturing hub globally, says report - The ...
Read more: India emerges as second most attractive manufacturing hub globally, says report - The ...
Pharma Reviews: Pharma Long-Term Bet; Corrections Good Entry Point For Quality Stocks: Dsp Investment Managers
According to him, pharmaceutical sector generally is a good long-term bet. “India as a country has a good advantage in terms of being low cost, having good ...
Read more: Pharma Long-Term Bet; Corrections Good Entry Point For Quality Stocks: Dsp Investment Managers
Read more: Pharma Long-Term Bet; Corrections Good Entry Point For Quality Stocks: Dsp Investment Managers
Pharma Reviews: Chakri Lokapriya is betting on these 3 value buys in pharma. Should you? - The Economic Times
Large mechanised farms outside of India require different levels or types of crop protection methods. A global company like UPL is aware of what changes are ...
Read more: Chakri Lokapriya is betting on these 3 value buys in pharma. Should you? - The Economic Times
Read more: Chakri Lokapriya is betting on these 3 value buys in pharma. Should you? - The Economic Times
Pharma Reviews: BIG! Delhi Govt notifies Medical Oxygen Production Promotion Policy 2021 - Zee Business
Big development for Refex Industries and Linde India shares! The two companies are into manufacturing of oxygen. The Government of National Capital ...
Read more: BIG! Delhi Govt notifies Medical Oxygen Production Promotion Policy 2021 - Zee Business
Read more: BIG! Delhi Govt notifies Medical Oxygen Production Promotion Policy 2021 - Zee Business
Pharma Reviews: India's outpatient healthcare and doctor consultation market in 5 charts
Consultations typically lead to pharma prescriptions and diagnostic test prescriptions – in total the market for these three segments (the outpatient ...
Read more: India's outpatient healthcare and doctor consultation market in 5 charts
Read more: India's outpatient healthcare and doctor consultation market in 5 charts
Pharma Reviews: Stock Market Highlights: Sensex Gains 226 Points, Nifty Ends Near 16500 Led By It Stocks
Stock Market Highlights: Indian equity benchmarks Sensex and Nifty ended higher Monday led by gains in IT stocks. Broader markets underperformed the ...
Read more: Stock Market Highlights: Sensex Gains 226 Points, Nifty Ends Near 16500 Led By It Stocks
Read more: Stock Market Highlights: Sensex Gains 226 Points, Nifty Ends Near 16500 Led By It Stocks
Pharma Reviews: Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare And Other Stocks In News Today
Aurobindo Pharma: The company approved the termination of binding agreement with Cronus Pharma Specialities India for acquisition of 51% ownership in Cronus ...
Read more: Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare And Other Stocks In News Today
Read more: Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare And Other Stocks In News Today
Pharma Reviews: Sensex closes 226 pts higher, Nifty at 16, 496; auto, realty top drags; IT gains - Mint
“Indian markets started on a positive note following positive Asian ... Drug firm Zydus Cadila on Monday said it has received final approval from the US ...
Read more: Sensex closes 226 pts higher, Nifty at 16, 496; auto, realty top drags; IT gains - Mint
Read more: Sensex closes 226 pts higher, Nifty at 16, 496; auto, realty top drags; IT gains - Mint
Pharma Reviews: Stocks To Watch: Cadila Healthcare, Power Grid, Aurobindo Pharma, Max ... - BloombergQuint
This vaccine was developed domestically by Zydus Cadila in partnership with India's Department of Biotechnology. The company plans to manufacture 10-12 ...
Read more: Stocks To Watch: Cadila Healthcare, Power Grid, Aurobindo Pharma, Max ... - BloombergQuint
Read more: Stocks To Watch: Cadila Healthcare, Power Grid, Aurobindo Pharma, Max ... - BloombergQuint
Pharma Reviews: All You Need To Know Going Into Trade On August 23 - BloombergQuint
The Singapore-traded SGX Nifty, an early indicator of India's Nifty 50 Index's performance, ... Emcure Pharmaceuticals seeks SEBI approval for IPO.
Read more: All You Need To Know Going Into Trade On August 23 - BloombergQuint
Read more: All You Need To Know Going Into Trade On August 23 - BloombergQuint
Pharma Reviews: India's equity rally is now in its mid-cycle: Rahul Chadha - The Economic Times
We like metals, auto, and generic pharma companies. In the past, we have liked telecom companies but now we think the growth tailwind is in the industrials ...
Read more: India's equity rally is now in its mid-cycle: Rahul Chadha - The Economic Times
Read more: India's equity rally is now in its mid-cycle: Rahul Chadha - The Economic Times
Pharma Reviews: GSK bets on specialty drugs, jabs for growth after drab Q1 - Mint
GlaxoSmithKline Pharmaceuticals Ltd's (GSK's) shares have been an underperformer. ... The strong rebound in Indian pharma market growth with improving acute ...
Read more: GSK bets on specialty drugs, jabs for growth after drab Q1 - Mint
Read more: GSK bets on specialty drugs, jabs for growth after drab Q1 - Mint
Pharma Reviews: 4 Highest Piotroski Score Stocks In Nifty 500 - Goodreturns
Torrent Pharmaceuticals Ltd is an Indian global pharmaceutical firm headquartered in Ahmedabad, India, and controlled by the Torrent Group.
Read more: 4 Highest Piotroski Score Stocks In Nifty 500 - Goodreturns
Read more: 4 Highest Piotroski Score Stocks In Nifty 500 - Goodreturns
Pharma Reviews: Pharma companies' charity hope for kids with rare spinal disorder - The Economic Times
By the time parents reach out to the doctors, there has already been a delay. Agencies Representative Image. Indian pharmaceutical companies are running charity ...
Read more: Pharma companies' charity hope for kids with rare spinal disorder - The Economic Times
Read more: Pharma companies' charity hope for kids with rare spinal disorder - The Economic Times
Pharma Reviews: US generic business saw pricing headwinds during 1Q FY22: India Ratings - Free Press Journal
India Ratings said most Indian pharma companies have witnessed a decline in US generic business on a quarterly and yearly basis/ Representational image.
Read more: US generic business saw pricing headwinds during 1Q FY22: India Ratings - Free Press Journal
Read more: US generic business saw pricing headwinds during 1Q FY22: India Ratings - Free Press Journal
Pharma Reviews: What cues will market watch out for from Fed's Jackson Hole retreat? - The Economic Times
There have been challenges for Indian pharma on the regulatory front. Most of the larger pharma companies have got their act together.
Read more: What cues will market watch out for from Fed's Jackson Hole retreat? - The Economic Times
Read more: What cues will market watch out for from Fed's Jackson Hole retreat? - The Economic Times
Pharma Reviews: PharmaLytica 2021 returns in a hybrid format - PrintWeek India
The two-day in-person event was inaugurated by Shri Ravi Uday Bhaskar, director general, Pharmaceuticals Export Promotion Council of India; ...
Read more: PharmaLytica 2021 returns in a hybrid format - PrintWeek India
Read more: PharmaLytica 2021 returns in a hybrid format - PrintWeek India
US FDA News: Cardinal Health Recalls Monoject Saline Flush Prefilled Syringes for Risk of Air Re-entering Syringe Leading to Air Embolism
Monoject Saline Prefilled Flush Syringes recalled. Syringe plungers may let air back into the syringe, leading to air embolism
Read more: Cardinal Health Recalls Monoject Saline Flush Prefilled Syringes for Risk of Air Re-entering Syringe Leading to Air Embolism
Read more: Cardinal Health Recalls Monoject Saline Flush Prefilled Syringes for Risk of Air Re-entering Syringe Leading to Air Embolism
US FDA News: FDA and Mexican Counterparts Report Progress and Next Steps for Food Safety Partnership
FDA and its regulatory counterparts in Mexico held the first Food Safety Partnership Annual Meeting.
Read more: FDA and Mexican Counterparts Report Progress and Next Steps for Food Safety Partnership
Read more: FDA and Mexican Counterparts Report Progress and Next Steps for Food Safety Partnership
US FDA News: FDA Approves First COVID-19 Vaccine
FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older.
Read more: FDA Approves First COVID-19 Vaccine
Read more: FDA Approves First COVID-19 Vaccine
Friday, August 20, 2021
US FDA News: Coronavirus (COVID-19) Update: August 20, 2021
Coronavirus (COVID-19) Update: August 20, 2021
Read more: Coronavirus (COVID-19) Update: August 20, 2021
Read more: Coronavirus (COVID-19) Update: August 20, 2021
US FDA News: UPDATE: Caution with Robotically-Assisted Surgical Devices in Mastectomy: FDA Safety Communication
FDA reminds patients and healthcare providers the safety and effectiveness of RAS devices in mastectomy or breast cancer treatment has not been established
Read more: UPDATE: Caution with Robotically-Assisted Surgical Devices in Mastectomy: FDA Safety Communication
Read more: UPDATE: Caution with Robotically-Assisted Surgical Devices in Mastectomy: FDA Safety Communication
US FDA News: Cardinal Health Issues Nationwide Recall of Select Monoject™ Flush Prefilled Saline Syringes
On August 4, 2021, Cardinal Health (NYSE: CAH) initiated a nationwide recall of approximately 267 million MonojectTM Flush Prefilled Saline Syringes (0.9% Sodium Chloride). The products have been found to reintroduce air into the syringe after the air has been expelled. This could result in injectio
Read more: Cardinal Health Issues Nationwide Recall of Select Monoject™ Flush Prefilled Saline Syringes
Read more: Cardinal Health Issues Nationwide Recall of Select Monoject™ Flush Prefilled Saline Syringes
US FDA News: Cardinal Health Recalls Argyle UVC Insertion Tray Due to Missing Instructions for Use for the Safety Scalpel N11
Cardinal Health recalls the Argyle Umbilical Venous Catheter Insertion Tray due to missing instructions for use for the included Safety Scalpel N11.
Read more: Cardinal Health Recalls Argyle UVC Insertion Tray Due to Missing Instructions for Use for the Safety Scalpel N11
Read more: Cardinal Health Recalls Argyle UVC Insertion Tray Due to Missing Instructions for Use for the Safety Scalpel N11
Wednesday, August 18, 2021
Pharma Reviews: Exporters want steel, pharmaceuticals sectors under RoDTEP scheme | Business Standard News
Especially at a time when (pharma) exports are doing well. Competition is also increasing in the sector,” said Sudarshan Jain, secretary general, Indian ...
Read more: Exporters want steel, pharmaceuticals sectors under RoDTEP scheme | Business Standard News
Read more: Exporters want steel, pharmaceuticals sectors under RoDTEP scheme | Business Standard News
Pharma Reviews: PharmaLytica 2021 successfully returns in a Hybrid Format - India Education Diary
India's Largest Pharmaceutical Marketplace for Pharma Packaging, Machinery, Lab, & Analytical Services ... Hyderabad : The 7th edition of PharmaLytica organised ...
Read more: PharmaLytica 2021 successfully returns in a Hybrid Format - India Education Diary
Read more: PharmaLytica 2021 successfully returns in a Hybrid Format - India Education Diary
Pharma Reviews: PharmaLytica 2021 successfully returns in a Hybrid Format | NewsPatrolling.com
India's Largest Pharmaceutical Marketplace for Pharma Packaging, Machinery, Lab, & Analytical Services. Mumbai, 18th August 2021: The 7th edition ...
Read more: PharmaLytica 2021 successfully returns in a Hybrid Format | NewsPatrolling.com
Read more: PharmaLytica 2021 successfully returns in a Hybrid Format | NewsPatrolling.com
US FDA News: Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots
Public health and medical experts from the U.S. Department of Health and Human Services released a statement on the Administration’s plan for COVID-19 booster shots for the American people.
Read more: Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots
Read more: Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots
US FDA News: 2021 Safety Communications
The FDA posts Medical Device Safety Communications to describe the FDA's current analysis of an issue and contain specific regulatory approaches and clinical recommendations for patient management.
Read more: 2021 Safety Communications
Read more: 2021 Safety Communications
US FDA News: Stop Using All Eco-Med Ultrasound Gels and Lotions Due to Risk of Bacterial Contamination – Letter to Health Care Providers
Ultrasound gels and lotions manufactured by Eco-Med are at risk for bacterial contamination.
Read more: Stop Using All Eco-Med Ultrasound Gels and Lotions Due to Risk of Bacterial Contamination – Letter to Health Care Providers
Read more: Stop Using All Eco-Med Ultrasound Gels and Lotions Due to Risk of Bacterial Contamination – Letter to Health Care Providers
Pharma Reviews: Accelerating the Process Scale Up - Get it first time right - Express Pharma
Ansys Executive Presentation: Simulation Driven Innovation in Pharma Industry ... + Hemant Punekar, Healthcare Expert- India, Ansys
Read more: Accelerating the Process Scale Up - Get it first time right - Express Pharma
Read more: Accelerating the Process Scale Up - Get it first time right - Express Pharma
Pharma Reviews: Sensex, Nifty trade lower dragged by metals, realty stocks; midcaps outperform - CNBCTV18
The Indian benchmark had a positive start in the market following the positive ... Sun Pharmaceutical Industries' FY21 annual report emphasises ramping up ...
Read more: Sensex, Nifty trade lower dragged by metals, realty stocks; midcaps outperform - CNBCTV18
Read more: Sensex, Nifty trade lower dragged by metals, realty stocks; midcaps outperform - CNBCTV18
Pharma Reviews: Wellness Forever opens 15 new pharmacies across 3 Indian states - ET HealthWorld
Wellness Forever pharmacy chain announced the opening of 15 new stores across ... by reputed Indian and international companies, said the release.
Read more: Wellness Forever opens 15 new pharmacies across 3 Indian states - ET HealthWorld
Read more: Wellness Forever opens 15 new pharmacies across 3 Indian states - ET HealthWorld
Tuesday, August 17, 2021
Pharma Reviews: Regulators should align to formulate standards for the approval of generic and biosimilar ...
The Indian Pharmaceutical Industry is at an inflection point like the Indian IT industry which blossomed in the 1990s-2000s. The pharma sector has the ...
Read more: Regulators should align to formulate standards for the approval of generic and biosimilar ...
Read more: Regulators should align to formulate standards for the approval of generic and biosimilar ...
Pharma Reviews: Serum Institute picks up 50% in glass vial maker Schott's Indian JV | Business Standard News
Sources in the know say that now Dadachanji and Mistry would focus on bringing in new pharmaceutical products – both drugs and drug delivery ...
Read more: Serum Institute picks up 50% in glass vial maker Schott's Indian JV | Business Standard News
Read more: Serum Institute picks up 50% in glass vial maker Schott's Indian JV | Business Standard News
US FDA News: FDA In Brief: FDA Issues a Corporate-Wide Warning Letter to Company Associated with Contaminated Pet Food, Hundreds of Adverse Events
The FDA has issued a corporate-wide warning letter to Midwestern Pet Foods, Inc. after inspections of its manufacturing sites revealed apparent violations of the Federal Food, Drug, and Cosmetic Act shared across multiple sites
Read more: FDA In Brief: FDA Issues a Corporate-Wide Warning Letter to Company Associated with Contaminated Pet Food, Hundreds of Adverse Events
Read more: FDA In Brief: FDA Issues a Corporate-Wide Warning Letter to Company Associated with Contaminated Pet Food, Hundreds of Adverse Events
Pharma Reviews: Serum Institute of India buys 50% stake of SCHOTT Kaisha, becomes joint venture partner
The joint venture is the leading Indian manufacturer of pharma packaging products such as vials, syringes, ampoules and cartridges used to package ...
Read more: Serum Institute of India buys 50% stake of SCHOTT Kaisha, becomes joint venture partner
Read more: Serum Institute of India buys 50% stake of SCHOTT Kaisha, becomes joint venture partner
Pharma Reviews: COVID-19 vaccine: India plans $11 bn market opportunity - BusinessToday
India's pharmaceutical sector is looking at an opportunity to the tune of $10 to 11 billion in the form of COVID-19 vaccine supply, in both domestic and ...
Read more: COVID-19 vaccine: India plans $11 bn market opportunity - BusinessToday
Read more: COVID-19 vaccine: India plans $11 bn market opportunity - BusinessToday
Pharma Reviews: Market LIVE: Sensex, Nifty move between gains and losses in volatile trade - The Financial Express
BSE Sensex was hovering around 55,630 and the Nifty 50 index was flat at 16,562. Tech Mahindra, Sun Pharma, Nestle India, Power Grid Corporation ...
Read more: Market LIVE: Sensex, Nifty move between gains and losses in volatile trade - The Financial Express
Read more: Market LIVE: Sensex, Nifty move between gains and losses in volatile trade - The Financial Express
Monday, August 16, 2021
Pharma Reviews: Covid-19 vaccine: India looking at $11 billion market opportunity - The Economic Times
Agencies As of August 10, 2021, over 4.35 billion Covid-19 vaccine shots have been administered globally. India's pharmaceutical sector is looking at ...
Read more: Covid-19 vaccine: India looking at $11 billion market opportunity - The Economic Times
Read more: Covid-19 vaccine: India looking at $11 billion market opportunity - The Economic Times
US FDA News: Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX® (varenicline) Tablets Due to N- Nitroso Varenicline Content
Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily Intake (ADI) level.
Read more: Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX® (varenicline) Tablets Due to N- Nitroso Varenicline Content
Read more: Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX® (varenicline) Tablets Due to N- Nitroso Varenicline Content
Pharma Reviews: Healthtech entrepreneurs must scale amid Indian startup boom
"Now over 300 AI companies are working on medical imaging. The new-age technology can surely transform the Indian healthtech sector.
Read more: Healthtech entrepreneurs must scale amid Indian startup boom
Read more: Healthtech entrepreneurs must scale amid Indian startup boom
Pharma Reviews: Pharma Leadership Forum 2021
The pharmaceutical industry, like most sectors, is undergoing radical ... Pharma Leadership Forum 2021 conducted by Express Pharma (Indian ...
Read more: Pharma Leadership Forum 2021
Read more: Pharma Leadership Forum 2021
Pharma Reviews: Stock Market LIVE Updates: Sensex, Nifty trade higher; metals shine; banks, pharma drag ...
Stock Market LIVE Updates: The Indian equity indices, Sensex and Nifty are trading higher Monday led by gains in metals and FMCG stocks. Broader ...
Read more: Stock Market LIVE Updates: Sensex, Nifty trade higher; metals shine; banks, pharma drag ...
Read more: Stock Market LIVE Updates: Sensex, Nifty trade higher; metals shine; banks, pharma drag ...
Sunday, August 15, 2021
Pharma Reviews: Why regulating nitrosamines in India will prove challenging
Unlike the US drug regulator, however, the Indian drug regulator, CDSCO, does not yet require the pharma industry to control for nitrosamines.
Read more: Why regulating nitrosamines in India will prove challenging
Read more: Why regulating nitrosamines in India will prove challenging
Pharma Reviews: The toxic drug impurity imperilling Indians
The detection of carcinogenic compounds in commonly used drugs has plunged the global pharma industry into crisis mode. India's drug regulator ...
Read more: The toxic drug impurity imperilling Indians
Read more: The toxic drug impurity imperilling Indians
Pharma Reviews: Scripting independent India's pharma industry journey from non-existent to a world leader
The Indian pharmaceutical industry, thus, emerged as a dependable partner and demonstrated tremendous commitment towards patients across ...
Read more: Scripting independent India's pharma industry journey from non-existent to a world leader
Read more: Scripting independent India's pharma industry journey from non-existent to a world leader
Pharma Reviews: Azadi journey so far. Achievements and the way ahead
India has made noteworthy progress in the health and pharmaceutical industry, from importing medicines some decades ago to now manufacturing ...
Read more: Azadi journey so far. Achievements and the way ahead
Read more: Azadi journey so far. Achievements and the way ahead
Friday, August 13, 2021
Pharma Reviews: China is out to strangle India's bulk drug makers. The government needs to heed the industry's SOS.
Two decades ago, the turnaround specialist with a bank was reviewing a sick manufacturing unit in Hyderabad that had everything going for it, but an ...
Read more: China is out to strangle India's bulk drug makers. The government needs to heed the industry's SOS.
Read more: China is out to strangle India's bulk drug makers. The government needs to heed the industry's SOS.
Pharma Reviews: Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
The Indian animal healthcare market is estimated to be around Rs. 5,500 crore ... Pharma and healthcare sector is witnessing robust private equity ...
Read more: Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
Read more: Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
Pharma Reviews: Bull run in drug stocks face first hurdle as old headache returns
Sun Pharmaceutical Industries, India's largest generic drug maker, suggested predicting a bottom for price erosion in the US market “is the million ...
Read more: Bull run in drug stocks face first hurdle as old headache returns
Read more: Bull run in drug stocks face first hurdle as old headache returns
Pharma Reviews: Understanding the nuances of generics injectables
North America and India are major generic drug manufacturers. ... India's pharmaceutical industry, and also mentioned the learnings in supply chain ...
Read more: Understanding the nuances of generics injectables
Read more: Understanding the nuances of generics injectables
Pharma Reviews: Environment ministry quashes limits for discharge of antibiotic residue in water bodies
... pharmaceutical industry was made even as the menace of antimicrobial resistance is being warned against by the public health experts in India.
Read more: Environment ministry quashes limits for discharge of antibiotic residue in water bodies
Read more: Environment ministry quashes limits for discharge of antibiotic residue in water bodies
Pharma Reviews: Fitterfly, Economic Times, Roche, USV and Lal Path labs to launch India's largest awareness ...
Fitterfly is the preferred digital therapeutic partner for many doctors, hospitals, organisations like pharma companies, corporates and medical device ...
Read more: Fitterfly, Economic Times, Roche, USV and Lal Path labs to launch India's largest awareness ...
Read more: Fitterfly, Economic Times, Roche, USV and Lal Path labs to launch India's largest awareness ...
Pharma Reviews: Market LIVE Updates: Sensex above 55400, Nifty at 16500; realty, pharma drag
Indian indices touch new highs after market opening on Friday. Data released by the National Statistical Office showed retail inflation eased to 5.59% ...
Read more: Market LIVE Updates: Sensex above 55400, Nifty at 16500; realty, pharma drag
Read more: Market LIVE Updates: Sensex above 55400, Nifty at 16500; realty, pharma drag
Pharma Reviews: We are redefining scope of antibiotics through innovative R&D: Saransh Chaudhary, CEO, Venus ...
Growth outlook for pharma sector in view of Covid-19. The growth outlook for the Indian pharmaceutical sector, which has remained largely resilient in ...
Read more: We are redefining scope of antibiotics through innovative R&D: Saransh Chaudhary, CEO, Venus ...
Read more: We are redefining scope of antibiotics through innovative R&D: Saransh Chaudhary, CEO, Venus ...
Pharma Reviews: Industry should domestically manufacture off patent medicines under Atmanirbhar Bharat: Mandaviya
He was speaking during the session on Ensuring Affordable, Accessible Health for All at the Confederation of Indian Industry (CII) Annual Meeting ...
Read more: Industry should domestically manufacture off patent medicines under Atmanirbhar Bharat: Mandaviya
Read more: Industry should domestically manufacture off patent medicines under Atmanirbhar Bharat: Mandaviya
Pharma Reviews: Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
Global animal health industry will grow at a CAGR of 4.8% to reach $ 45 billion by 2025 while India's animal healthcare market stood at $460 million in ...
Read more: Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
Read more: Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
Pharma Reviews: Made-in-India Drug to Cure Mild Covid Patients Has Antibodies Developed in Horses; to be Out Soon
iSERA Biological said the company might able to deliver the drug at a tenth of the cost charged by the alternative antibody cocktail developed by pharma ...
Read more: Made-in-India Drug to Cure Mild Covid Patients Has Antibodies Developed in Horses; to be Out Soon
Read more: Made-in-India Drug to Cure Mild Covid Patients Has Antibodies Developed in Horses; to be Out Soon
Thursday, August 12, 2021
US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals
The FDA amended the EUAs for the Pfizer-BioNTech and Moderna COVID-19 Vaccines to allow an additional dose in certain immunocompromised individuals, specifically solid organ transplant recipients or those with conditions that are considered to have an equivalent level of immunocompromise.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals
US FDA News: FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
Today, the FDA approved a novel indication for drug Xywav
Read more: FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
Read more: FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
US FDA News: Medtronic Stops Distribution and Sale of HeartWare HVAD System Due to Risk of Neurological Adverse Events, Mortality, and Potential Failure to Restart
Increased risk of neurological adverse events, mortality and possible failure of the pump to restart led to stop sale and distribution of HeartWare HVAD System
Read more: Medtronic Stops Distribution and Sale of HeartWare HVAD System Due to Risk of Neurological Adverse Events, Mortality, and Potential Failure to Restart
Read more: Medtronic Stops Distribution and Sale of HeartWare HVAD System Due to Risk of Neurological Adverse Events, Mortality, and Potential Failure to Restart
US FDA News: Baxter Healthcare Recalls Dose IQ Software Version 9.0.x, Used with Spectrum IQ Infusion Pumps, for Software Defect That May Improperly Configure Drug and Fluid Delivery
A software defect in Baxter’s Dose IQ Software version 9.0.x may impact how fluid is delivered to a patient with the Spectrum IQ Infusion Pump
Read more: Baxter Healthcare Recalls Dose IQ Software Version 9.0.x, Used with Spectrum IQ Infusion Pumps, for Software Defect That May Improperly Configure Drug and Fluid Delivery
Read more: Baxter Healthcare Recalls Dose IQ Software Version 9.0.x, Used with Spectrum IQ Infusion Pumps, for Software Defect That May Improperly Configure Drug and Fluid Delivery
Pharma Reviews: Implications of a remote workforce on data security in pharma and ways to rise above them
Storage, management, and processing of sensitive data outside of company networks: Pharmaceutical companies aren't just producers but collectors of ...
Read more: Implications of a remote workforce on data security in pharma and ways to rise above them
Read more: Implications of a remote workforce on data security in pharma and ways to rise above them
Wednesday, August 11, 2021
Pharma Reviews: Stock Market LIVE Updates: Sensex, Nifty50 move higher led by auto, IT shares; broader markets ...
On the other hand, selling pressure in Sun Pharma, Tata Steel and Axis Bank ... Key bond market deals: Food Corporation of India, Hero Fincorp, IOC.
Read more: Stock Market LIVE Updates: Sensex, Nifty50 move higher led by auto, IT shares; broader markets ...
Read more: Stock Market LIVE Updates: Sensex, Nifty50 move higher led by auto, IT shares; broader markets ...
Pharma Reviews: Post COVID: Pharmaceutical Industry has become Alluring Career Option
According to IBEF, Indian pharmaceutical sector supplies over 50% of global demand for various vaccines and also states that India is the largest ...
Read more: Post COVID: Pharmaceutical Industry has become Alluring Career Option
Read more: Post COVID: Pharmaceutical Industry has become Alluring Career Option
US FDA News: Jongu 4308 Issues Voluntary Nationwide Recall of Hydro Pineapple Burn Due to the Presence of Undeclared Sibutramine.
[eBay Seller ID: jongu 4308] is voluntarily recalling all lots of Hydro Pineapple Burn to consumer level. FDA analysis has found the product to contain undeclared sibutramine. Sibutramine was an FDA approved drug used as an appetite suppressant for weight loss but was withdrawn from the market beca
Read more: Jongu 4308 Issues Voluntary Nationwide Recall of Hydro Pineapple Burn Due to the Presence of Undeclared Sibutramine.
Read more: Jongu 4308 Issues Voluntary Nationwide Recall of Hydro Pineapple Burn Due to the Presence of Undeclared Sibutramine.
Pharma Reviews: Windlas Biotech IPO share allotment likely to be finalised on August 11
The company has developed relationships with leading Indian pharmaceutical companies, including Pfizer, Sanofi India, Cadila Healthcare/ Zydus ...
Read more: Windlas Biotech IPO share allotment likely to be finalised on August 11
Read more: Windlas Biotech IPO share allotment likely to be finalised on August 11
Pharma Reviews: 7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
Supported by the Pharmaceutical Export Promotion Council of India (Pharmexcil) and Confederation Of Indian Pharmaceutical Industry (CiPi), the ...
Read more: 7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
Read more: 7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
Pharma Reviews: Market LIVE Updates: Sensex, Nifty off day's lows; pharma drags, metals shine
Market LIVE Updates: Sensex, Nifty off day's lows; pharma drags, metals shine. Stock Market Today: Indian indices were down 0.50% on Wednesday. ( ...
Read more: Market LIVE Updates: Sensex, Nifty off day's lows; pharma drags, metals shine
Read more: Market LIVE Updates: Sensex, Nifty off day's lows; pharma drags, metals shine
Pharma Reviews: 7th edition of PharmaLytica Expo on 13th August
Supported by Pharmaceutical Export Promotion Council of India ... of Indian Pharmaceutical Industry (CiPi) the PharmaLytica Expo will include ...
Read more: 7th edition of PharmaLytica Expo on 13th August
Read more: 7th edition of PharmaLytica Expo on 13th August
Pharma Reviews: Top performing sectors in 2021
With vaccination drive in full swing, there's a good opportunity for pharma companies as India looks forward to various types of vaccine. The pharma ...
Read more: Top performing sectors in 2021
Read more: Top performing sectors in 2021
Pharma Reviews: Stock Market LIVE Updates: Sensex recovers 250 points from day's low, Nifty50 near 16250; metal ...
Sapphire Foods India Ltd, which operates KFC and Pizza Hut outlets in the ... After market hours on Tuesday, Krishna Institute of Medical Sciences ...
Read more: Stock Market LIVE Updates: Sensex recovers 250 points from day's low, Nifty50 near 16250; metal ...
Read more: Stock Market LIVE Updates: Sensex recovers 250 points from day's low, Nifty50 near 16250; metal ...
Tuesday, August 10, 2021
US FDA News: SterRx, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL Due to Microbial Contamination
SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC has initiated this voluntary recall of Sodium Bicarbonate injection, to the Hospital Pharmacy level.
Read more: SterRx, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL Due to Microbial Contamination
Read more: SterRx, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL Due to Microbial Contamination
US FDA News: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Transition to Safety Mode
Boston Scientific recalls INGENIO Family of Pacemakers and CRT-Ps, used to treat slower than normal heartbeats and heart failure, due to the risk of transitioning to safety mode.
Read more: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Transition to Safety Mode
Read more: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Transition to Safety Mode
Pharma Reviews: Hyderabad to host seventh edition of PharmaLytica in hybrid mode
Supported by Pharmaceutical Export Promotion Council of India and Confederation of Indian Pharmaceutical Industry, the PharmaLytica Expo will see ...
Read more: Hyderabad to host seventh edition of PharmaLytica in hybrid mode
Read more: Hyderabad to host seventh edition of PharmaLytica in hybrid mode
Pharma Reviews: Covid-hit Africa yearns for Indian medicines, vaccines
The country is already the largest vaccine manufacturer, going ahead we need to look at ways by which India can also collaborate in investing in setting ...
Read more: Covid-hit Africa yearns for Indian medicines, vaccines
Read more: Covid-hit Africa yearns for Indian medicines, vaccines
Pharma Reviews: Additional certification schemes in MedTech sector to impact ease of doing business and ...
The Quality Council of India has recently launched a local medical device certification scheme called Indian Certification for Medical Devices (ICMED) ...
Read more: Additional certification schemes in MedTech sector to impact ease of doing business and ...
Read more: Additional certification schemes in MedTech sector to impact ease of doing business and ...
Pharma Reviews: 7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
India's Largest Pharmaceutical Marketplace for Pharma Packaging, Machinery, Lab, & Analytical Services ... Mumbai: Informa Markets in India, India's ...
Read more: 7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
Read more: 7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
Pharma Reviews: How will the Indian stock market add the next trillion dollar m-cap? Nilesh Shah explains
In pharma, we have seen selective pharma companies outperforming the broad markets. Now onwards, with the rerating behind us, it will be a company ...
Read more: How will the Indian stock market add the next trillion dollar m-cap? Nilesh Shah explains
Read more: How will the Indian stock market add the next trillion dollar m-cap? Nilesh Shah explains
Pharma Reviews: Zydus Cadila ZyCoV-D likely to get emergency use nod this week: Sources
... "The government expects that in October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that ...
Read more: Zydus Cadila ZyCoV-D likely to get emergency use nod this week: Sources
Read more: Zydus Cadila ZyCoV-D likely to get emergency use nod this week: Sources
Pharma Reviews: Disruptive Trends Impacting Pharma Industry
Indian pharmaceutical industry is unique. Unlike the western world, we have a unique concept of branded generics. For any given medicinal drug, ...
Read more: Disruptive Trends Impacting Pharma Industry
Read more: Disruptive Trends Impacting Pharma Industry
Pharma Reviews: Demystifying pharma procurement: Opportunities, challenges and way forward
Therefore, Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a webinar ...
Read more: Demystifying pharma procurement: Opportunities, challenges and way forward
Read more: Demystifying pharma procurement: Opportunities, challenges and way forward
Pharma Reviews: Market LIVE Updates: Sensex surges to new high, Nifty above 16300; IT gains
JLL, India's largest real estate consultancy firm, on Monday announced its entry into the country's ... Pharma, PSU banking stocks were top gainers.
Read more: Market LIVE Updates: Sensex surges to new high, Nifty above 16300; IT gains
Read more: Market LIVE Updates: Sensex surges to new high, Nifty above 16300; IT gains
Monday, August 9, 2021
Pharma Reviews: The Softgel Tumble Dryer Market Is Growing With the Rapid Growth of the Food and ...
According to the India Brand Equity Foundation (IBEF), Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device ...
Read more: The Softgel Tumble Dryer Market Is Growing With the Rapid Growth of the Food and ...
Read more: The Softgel Tumble Dryer Market Is Growing With the Rapid Growth of the Food and ...
Pharma Reviews: Why pharma API is the flavour of the season
India's active pharmaceutical ingredient (API) business has been catapulted from pariah to private equity darling. The Indian pharma industry seems to ...
Read more: Why pharma API is the flavour of the season
Read more: Why pharma API is the flavour of the season
Pharma Reviews: Sensex closes 125 pts higher, Nifty at 16258; metals, top drags; IT, media gain
Astrazeneca Pharma India trades lower. Astrazeneca Pharma India's stock was trading at ₹3,369.60 each, down 1.08% at 3:20 pm. The company ...
Read more: Sensex closes 125 pts higher, Nifty at 16258; metals, top drags; IT, media gain
Read more: Sensex closes 125 pts higher, Nifty at 16258; metals, top drags; IT, media gain
Pharma Reviews: Best practices to manage current Pandemic crisis – join FE Healthcare Summit towards ...
India's healthcare industry has been growing at a Compound Annual ... of the North Indian states are gearing up to woo investors into pharmaceutical ...
Read more: Best practices to manage current Pandemic crisis – join FE Healthcare Summit towards ...
Read more: Best practices to manage current Pandemic crisis – join FE Healthcare Summit towards ...
Pharma Reviews: Indian medical device market to be supported by infrastructure, reform: Fitch
Singapore: The Make In India initiative will be a long-term driver of local medical device manufacturing, Fitch Solutions has said. The scheme will ...
Read more: Indian medical device market to be supported by infrastructure, reform: Fitch
Read more: Indian medical device market to be supported by infrastructure, reform: Fitch
Sunday, August 8, 2021
Pharma Reviews: MC Insider: Returning to work, DRHP filing frenzy, PE firms turn head hunters and more
Private Equity investors who are flocking to get a slice of India's pharma market and its low cost manufacturing advantage, are also creating a new ...
Read more: MC Insider: Returning to work, DRHP filing frenzy, PE firms turn head hunters and more
Read more: MC Insider: Returning to work, DRHP filing frenzy, PE firms turn head hunters and more
Pharma Reviews: For J&J, India may come across as lucrative mkt
... in America, India may come across as a lucrative market with Biological E as a local ... Indian health authorities have so far approved the use of vaccines ... Apart from these, Gennova Pharma's vaccine candidate, Bharat Biotech's ...
Read more: For J&J, India may come across as lucrative mkt
Read more: For J&J, India may come across as lucrative mkt
Friday, August 6, 2021
Pharma Reviews: COVID Vaccines: Where Does India Truly Stand on the TRIPS Waiver?
If a compulsory license was granted and Indian pharma companies manufactured large quantities of these two drugs, we could have the same impact on ...
Read more: COVID Vaccines: Where Does India Truly Stand on the TRIPS Waiver?
Read more: COVID Vaccines: Where Does India Truly Stand on the TRIPS Waiver?
US FDA News: Coronavirus (COVID-19) Update: August 6, 2021
Coronavirus (COVID-19) Update: August 6, 2021
Read more: Coronavirus (COVID-19) Update: August 6, 2021
Read more: Coronavirus (COVID-19) Update: August 6, 2021
Pharma Reviews: The rise and rise of the Indian hemp industry
The hemp industry in India is booming, with a new crop of entrepreneurs ready ... The Narcotic Drugs and Psychotropic Substances Act, 1985 bans the ...
Read more: The rise and rise of the Indian hemp industry
Read more: The rise and rise of the Indian hemp industry
Pharma Reviews: As COVID-19 cases drop, hiring at India Inc limps back
Here, healthcare/pharma leads the charts followed by the IT sector. Consumer goods companies and essential retail are among other sectors looking ...
Read more: As COVID-19 cases drop, hiring at India Inc limps back
Read more: As COVID-19 cases drop, hiring at India Inc limps back
Pharma Reviews: Sensex closes 215 pts lower, Nifty at 16238; RBI MPC keeps key rates unchanged
Drug firm Abbott India on Friday reported a 8.54 per cent rise in its net profit to ... The Indian job market has witnessed sequential growth for the second ...
Read more: Sensex closes 215 pts lower, Nifty at 16238; RBI MPC keeps key rates unchanged
Read more: Sensex closes 215 pts lower, Nifty at 16238; RBI MPC keeps key rates unchanged
US FDA News: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Incorrect Transition to Safety Mode
Boston Scientific recalls INGENIO Family of Pacemakers and CRT-Ps, used to treat slower than normal heartbeats and heart failure, due to the risk of incorrect transition to safety mode.
Read more: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Incorrect Transition to Safety Mode
Read more: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Incorrect Transition to Safety Mode
US FDA News: FDA Approves New Treatment for Pompe Disease
Today the FDA approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
Read more: FDA Approves New Treatment for Pompe Disease
Read more: FDA Approves New Treatment for Pompe Disease
Thursday, August 5, 2021
Pharma Reviews: Glenmark Life Sciences IPO may have four-digit listing, say experts
... Life Sciences shares are going to list today at Indian bourses. Shares of the Active Pharmaceutical Ingredients (APIs) manufacturer company will be ...
Read more: Glenmark Life Sciences IPO may have four-digit listing, say experts
Read more: Glenmark Life Sciences IPO may have four-digit listing, say experts
Pharma Reviews: Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
Indian pharma major Cipla on Thursday posted a net profit of Rs 715 crore in the ... The firm also recorded strong growth in its active pharmaceutical ...
Read more: Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
Read more: Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%
US FDA News: FDA In Brief: FDA Reminds Industry of Specific Regulations for the Use of Fluorinated Polyethylene in Food Contact Containers
FDA Reminds Industry of Specific Regulations for the Use of Fluorinated Polyethylene in Food Contact Containers
Read more: FDA In Brief: FDA Reminds Industry of Specific Regulations for the Use of Fluorinated Polyethylene in Food Contact Containers
Read more: FDA In Brief: FDA Reminds Industry of Specific Regulations for the Use of Fluorinated Polyethylene in Food Contact Containers
US FDA News: Eight Medical International Recalls Recirculator 8.0 Disposable Lavage Kits due to Potential Exposure to High Levels of Aluminum
When used for warming therapy, the Recirculator 8.0 Disposable Lavage Kit from Eight Medical may expose patients to high levels of aluminum.
Read more: Eight Medical International Recalls Recirculator 8.0 Disposable Lavage Kits due to Potential Exposure to High Levels of Aluminum
Read more: Eight Medical International Recalls Recirculator 8.0 Disposable Lavage Kits due to Potential Exposure to High Levels of Aluminum
Wednesday, August 4, 2021
Pharma Reviews: Windlas Biotech IPO opens for subscription; should you invest?
... efficient and quality compliant manufacturing facilities with significant entry barriers, long-term relationships with Indian pharmaceutical companies ...
Read more: Windlas Biotech IPO opens for subscription; should you invest?
Read more: Windlas Biotech IPO opens for subscription; should you invest?
Pharma Reviews: Windlas Biotech IPO to open today; here are key things to know
The company has developed relationships with various leading pharmaceutical companies including Pfizer Ltd, Sanofi India Ltd, Zydus Cadila ...
Read more: Windlas Biotech IPO to open today; here are key things to know
Read more: Windlas Biotech IPO to open today; here are key things to know
US FDA News: Eco-Med Pharmaceutical Issues Voluntary Recall of Eco-Gel 200
Eco-Med Pharmaceuticals, Inc. today commenced a voluntary recall of certain lots of its Eco-Gel 200 ultrasound gel due to bacterial contamination. The product is also distributed as MediChoice Ultrasound Gel by Owens and Minor and Mac Medical Supply. These ultrasound gels are non-sterile and not
Read more: Eco-Med Pharmaceutical Issues Voluntary Recall of Eco-Gel 200
Read more: Eco-Med Pharmaceutical Issues Voluntary Recall of Eco-Gel 200
US FDA News: FDA Participates in New ‘Collaborative Communities’ to Address Emerging Challenges in Medical Devices
The FDA announces participation in several new collaborative communities aimed at addressing challenges in patient health care.
Read more: FDA Participates in New ‘Collaborative Communities’ to Address Emerging Challenges in Medical Devices
Read more: FDA Participates in New ‘Collaborative Communities’ to Address Emerging Challenges in Medical Devices
Pharma Reviews: MMS Director Appointed to the Pharmacovigilance Council for the Indian Society of Clinical ...
Comprised of multinational Indian Pharma and CROs, doctors, site staff, ... in pharmacovigilance and drug safety within the pharmaceutical industry.”.
Read more: MMS Director Appointed to the Pharmacovigilance Council for the Indian Society of Clinical ...
Read more: MMS Director Appointed to the Pharmacovigilance Council for the Indian Society of Clinical ...
Pharma Reviews: Windlas Biotech IPO opens today: Should you subscribe? Brokerages weigh in
In FY2020, Windlas provided CDMO services to 7 of the top 10 Indian formulations pharmaceutical companies. The domestic formulations CDMO is ...
Read more: Windlas Biotech IPO opens today: Should you subscribe? Brokerages weigh in
Read more: Windlas Biotech IPO opens today: Should you subscribe? Brokerages weigh in
Pharma Reviews: Centre expedited supply of essential drugs for COVID : Mandaviya
Besides, Tocilizumab a patented drug of Hoffman La Roche, a Swiss multinational company, which is not manufactured in India and is available here via ...
Read more: Centre expedited supply of essential drugs for COVID : Mandaviya
Read more: Centre expedited supply of essential drugs for COVID : Mandaviya
Pharma Reviews: Centre increases supply of essential drugs for COVID
... granted by the patent holder to seven Indian pharmaceutical companies. ... the Drug Controller General of India (DCGI) coordinated with the industry ...
Read more: Centre increases supply of essential drugs for COVID
Read more: Centre increases supply of essential drugs for COVID
Tuesday, August 3, 2021
Pharma Reviews: Collaboration key to pharma's bright future
At the Accenture-ET Pharmaceuticals Leadership Dialogue, top industry ... Seventeen Indian generics companies have come together to invest in a ...
Read more: Collaboration key to pharma's bright future
Read more: Collaboration key to pharma's bright future
Pharma Reviews: To make India a start-up nation, open doors for Indian capital
Domestic capital looking to invest in the start-up sector still faces many ... Indian start-ups raised over $70 billion over 2014-2020—$11.5 billion in 2020 ... Indian-owned and managed, and so are the telecom and pharma industries, ...
Read more: To make India a start-up nation, open doors for Indian capital
Read more: To make India a start-up nation, open doors for Indian capital
Pharma Reviews: India initiates anti-dumping probe against Chinese pharma chemical
India has initiated an anti-dumping probe against a chemical used in the pharmaceutical industry imported from China, following a complaint filed by ...
Read more: India initiates anti-dumping probe against Chinese pharma chemical
Read more: India initiates anti-dumping probe against Chinese pharma chemical
US FDA News: Coronavirus (COVID-19) Update: August 3, 2021
Coronavirus (COVID-19) Update: August 3, 2021
Read more: Coronavirus (COVID-19) Update: August 3, 2021
Read more: Coronavirus (COVID-19) Update: August 3, 2021
US FDA News: Philips Respironics Recalls V60 and V60 Plus Ventilators Equipped with High Flow Therapy Software Versions 3.00 and 3.10 Due to Risk of Receiving Reduced Oxygen
Philips V60, V60 Plus ventilators provide breathing help to hospital patients. In high flow therapy they may reduce flow causing respiratory distress
Read more: Philips Respironics Recalls V60 and V60 Plus Ventilators Equipped with High Flow Therapy Software Versions 3.00 and 3.10 Due to Risk of Receiving Reduced Oxygen
Read more: Philips Respironics Recalls V60 and V60 Plus Ventilators Equipped with High Flow Therapy Software Versions 3.00 and 3.10 Due to Risk of Receiving Reduced Oxygen
Pharma Reviews: 4 more Indian pharma firms expected to start vaccine production by Oct-Nov: Health Minister
The government expects that by October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that will ...
Read more: 4 more Indian pharma firms expected to start vaccine production by Oct-Nov: Health Minister
Read more: 4 more Indian pharma firms expected to start vaccine production by Oct-Nov: Health Minister
Pharma Reviews: Windlas Biotech IPO: 10 key things to know before the issue opens
d) It has developed relationships with leading Indian pharmaceutical companies, including Pfizer, Sanofi India, Cadila Healthcare/ Zydus Healthcare, ...
Read more: Windlas Biotech IPO: 10 key things to know before the issue opens
Read more: Windlas Biotech IPO: 10 key things to know before the issue opens
Pharma Reviews: Nifty hits 16000 in historic day for Indian stock markets: 10 updates
Nifty Pharma is also supporting the current bullishness as big pharma ... "Sentiments in the Indian market remained positive with the GST collection ...
Read more: Nifty hits 16000 in historic day for Indian stock markets: 10 updates
Read more: Nifty hits 16000 in historic day for Indian stock markets: 10 updates
Pharma Reviews: Nifty ends a tad shy of 16150, Sensex soars 873 points; HDFC, Titan surge
The industry body leading the push, the Society of Indian Automobile Manufacturers (SIAM), is expected to meet the transport minister on Tuesday to ...
Read more: Nifty ends a tad shy of 16150, Sensex soars 873 points; HDFC, Titan surge
Read more: Nifty ends a tad shy of 16150, Sensex soars 873 points; HDFC, Titan surge
Pharma Reviews: Balaji Amines surges 9%, hits new high on robust June quarter results
Balaji Amines is the leading manufacturer of aliphatic amines in India, ... portfolio as the dependability on Indian pharma and agrochemicals industry ...
Read more: Balaji Amines surges 9%, hits new high on robust June quarter results
Read more: Balaji Amines surges 9%, hits new high on robust June quarter results
Pharma Reviews: Stock Market Live Updates: Nifty50 hits 16000 for first time as D-Street roars to record highs; IT ...
Sentiments in the Indian market remained positive with the GST collection ... Strong buying interest in IT, FMCG, pharma and select financial stocks ...
Read more: Stock Market Live Updates: Nifty50 hits 16000 for first time as D-Street roars to record highs; IT ...
Read more: Stock Market Live Updates: Nifty50 hits 16000 for first time as D-Street roars to record highs; IT ...
Monday, August 2, 2021
US FDA News: BD to Begin Remediation for BD Alaris™ System Software
FRANKLIN LAKES, N.J., July 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall through a new version of software.
Read more: BD to Begin Remediation for BD Alaris™ System Software
Read more: BD to Begin Remediation for BD Alaris™ System Software
Pharma Reviews: Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets
Drug firm Glenmark Pharmaceuticals on Monday said it has signed an agreement with Canadia's biotech firm SaNOtize Research and Development ...
Read more: Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets
Read more: Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets
Pharma Reviews: Achieving Aatmanirbharta in APIs: Are we on the right track?
For the last two decades, the Indian pharmaceutical industry has been ... Dr Viranchi Shah, Senior Vice President, Indian Drugs Manufacturers ...
Read more: Achieving Aatmanirbharta in APIs: Are we on the right track?
Read more: Achieving Aatmanirbharta in APIs: Are we on the right track?
Pharma Reviews: Stock Market Live Updates: Sensex, Nifty trade higher led by banks, auto stocks; Realty index ...
Stock Market Live Updates: Indian equity benchmarks Sensex and Nifty50 are ... Glenmark Pharmaceuticals and biotech firm SaNOtize Research and ...
Read more: Stock Market Live Updates: Sensex, Nifty trade higher led by banks, auto stocks; Realty index ...
Read more: Stock Market Live Updates: Sensex, Nifty trade higher led by banks, auto stocks; Realty index ...
Pharma Reviews: Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets
Drug firm. Glenmark Pharmaceuticals. on Monday said it has signed an agreement with Canadia's biotech firm SaNOtize Research and Development ...
Read more: Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets
Read more: Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets
Sunday, August 1, 2021
Pharma Reviews: Emcure Pharma strengthens its board; adding Independent Directors with illustrious background
Pune : Emcure Pharmaceuticals Ltd., one of India's leading pharma players continues to strengthen its leadership with appointment of distinguished ...
Read more: Emcure Pharma strengthens its board; adding Independent Directors with illustrious background
Read more: Emcure Pharma strengthens its board; adding Independent Directors with illustrious background
Subscribe to:
Comments (Atom)